Sobolewska-Włodarczyk A - Search Results

1

Treatment of the Fluoroquinolone-Associated Disability: The Pathobiochemical Implications.

Michalak K, Sobolewska-Włodarczyk A, Włodarczyk M, Sobolewska J, Woźniak P, Sobolewski B. Michalak K, et al. Oxid Med Cell Longev. 2017;2017:8023935. doi: 10.1155/2017/8023935. Epub 2017 Sep 25. Oxid Med Cell Longev. 2017. PMID: 29147464 Free PMC article. Review.

2

Pharmacology and metabolism of infliximab biosimilars - A new treatment option in inflammatory bowel diseases.

Włodarczyk M, Fichna J, Sobolewska-Włodarczyk A. Włodarczyk M, et al. Pharmacol Rep. 2016 Aug;68(4):797-801. doi: 10.1016/j.pharep.2016.04.006. Epub 2016 Apr 26. Pharmacol Rep. 2016. PMID: 27162107 Review.

3

The influence of family pattern abnormalities in the early stages of life on the course of inflammatory bowel diseases.

Włodarczyk M, Sobolewska-Włodarczyk A, Stec-Michalska K, Fichna J, Wiśniewska-Jarosińska M. Włodarczyk M, et al. Pharmacol Rep. 2016 Aug;68(4):852-8. doi: 10.1016/j.pharep.2016.04.008. Epub 2016 Apr 30. Pharmacol Rep. 2016. PMID: 27199029 Review.

4

Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome.

Sobolewska-Włodarczyk A, Włodarczyk M, Storr M, Fichna J. Sobolewska-Włodarczyk A, et al. Ther Clin Risk Manag. 2016 May 13;12:771-5. doi: 10.2147/TCRM.S83722. eCollection 2016. Ther Clin Risk Manag. 2016. PMID: 27257381 Free PMC article. Review.

5

Elevated risk of venous thromboembolic events in patients with inflammatory myopathies.

Nowak M, Królak-Nowak K, Sobolewska-Włodarczyk A, Fichna J, Włodarczyk M. Nowak M, et al. Vasc Health Risk Manag. 2016 Jun 3;12:233-8. doi: 10.2147/VHRM.S75308. eCollection 2016. Vasc Health Risk Manag. 2016. PMID: 27350751 Free PMC article. Review.

6

Genetic Molecular Subtypes in Optimizing Personalized Therapy for Metastatic Colorectal Cancer.

Włodarczyk M, Włodarczyk J, Siwiński P, Sobolewska-Włodarczyk A, Fichna J. Włodarczyk M, et al. Curr Drug Targets. 2018;19(15):1731-1737. doi: 10.2174/1389450119666180803122744. Curr Drug Targets. 2018. PMID: 30073926 Review.

7

Extraintestinal manifestations of Crohn's disease.

Wójcik B, Loga K, Włodarczyk M, Sobolewska-Włodarczyk A, Padysz M, Wiśniewska-Jarosińska M. Wójcik B, et al. Prz Gastroenterol. 2016;11(3):218-221. doi: 10.5114/pg.2016.61439. Epub 2016 Aug 5. Prz Gastroenterol. 2016. PMID: 27713787 Free PMC article. No abstract available.

8

The incidence rate of surgical interventions in patients with Crohn's disease treated with anti-tumour necrosis factor biologics.

Sobolewska-Włodarczyk A, Zielińska A, Siwiński P, Jędraszczyk E, Stec-Michalska K, Włodarczyk M, Wiśniewska-Jarosińska M. Sobolewska-Włodarczyk A, et al. Folia Med Cracov. 2017;57(2):95-104. Folia Med Cracov. 2017. PMID: 29121041 Free article.

9

Alopecia areata in patients with inflammatory bowel disease: an overview.

Sobolewska-Włodarczyk A, Włodarczyk M, Fichna J, Wiśniewska-Jarosińska M. Sobolewska-Włodarczyk A, et al. Folia Med Cracov. 2016;56(1):5-12. Folia Med Cracov. 2016. PMID: 27513834 Free article. Review.

10

Current concepts in the pathogenesis of cryptoglandular perianal fistula.

Włodarczyk M, Włodarczyk J, Sobolewska-Włodarczyk A, Trzciński R, Dziki Ł, Fichna J. Włodarczyk M, et al. Among authors: sobolewska wlodarczyk a. J Int Med Res. 2021 Feb;49(2):300060520986669. doi: 10.1177/0300060520986669. J Int Med Res. 2021. PMID: 33595349 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters